000144812 001__ 144812
000144812 005__ 20240229123020.0
000144812 0247_ $$2doi$$a10.1002/ijc.32674
000144812 0247_ $$2pmid$$apmid:31506954
000144812 0247_ $$2ISSN$$a0020-7136
000144812 0247_ $$2ISSN$$a1097-0215
000144812 0247_ $$2altmetric$$aaltmetric:66488992
000144812 037__ $$aDKFZ-2019-02237
000144812 041__ $$aeng
000144812 082__ $$a610
000144812 1001_ $$aCervenka, I.$$b0
000144812 245__ $$aExogenous Hormone Use and Cutaneous Melanoma Risk in Women: The European Prospective Investigation Into Cancer and Nutrition.
000144812 260__ $$aBognor Regis$$bWiley-Liss$$c2020
000144812 3367_ $$2DRIVER$$aarticle
000144812 3367_ $$2DataCite$$aOutput Types/Journal article
000144812 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1588843833_15569
000144812 3367_ $$2BibTeX$$aARTICLE
000144812 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144812 3367_ $$00$$2EndNote$$aJournal Article
000144812 500__ $$a2020 Jun 15;146(12):3267-3280
000144812 520__ $$aEvidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country-specific self-administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992-2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline-significant association between OC use and melanoma risk (HR=1.12, 95% CI=1.00-1.26), with no detected heterogeneity across countries (Phomogeneity =0.42). This risk increased linearly with duration of use (Ptrend =0.01). Among postmenopausal women, ever use of MHT was associated with a non-significant increase in melanoma risk overall (HR=1.14, 95% CI=0.97-1.43), which was heterogeneous across countries (Phomogeneity =0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations. This article is protected by copyright. All rights reserved.
000144812 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000144812 588__ $$aDataset connected to CrossRef, PubMed,
000144812 7001_ $$aAl Rahmoun, M.$$b1
000144812 7001_ $$aMahamat-Saleh, Y.$$b2
000144812 7001_ $$aFournier, A.$$b3
000144812 7001_ $$00000-0002-5956-5693$$aBoutron-Ruault, M. C.$$b4
000144812 7001_ $$aSeveri, G.$$b5
000144812 7001_ $$aCaini, S.$$b6
000144812 7001_ $$aPalli, D.$$b7
000144812 7001_ $$00000-0002-5466-7308$$aGhiasvand, R.$$b8
000144812 7001_ $$aVeierod, M. B.$$b9
000144812 7001_ $$00000-0002-9023-8068$$aBotteri, E.$$b10
000144812 7001_ $$aTjønneland, A.$$b11
000144812 7001_ $$aOlsen, A.$$b12
000144812 7001_ $$0P:(DE-HGF)0$$aFortner, R. T.$$b13
000144812 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, R.$$b14$$udkfz
000144812 7001_ $$aSchulze, M. B.$$b15
000144812 7001_ $$aPanico, S.$$b16
000144812 7001_ $$aTrichopoulou, A.$$b17
000144812 7001_ $$aDessinioti, C.$$b18
000144812 7001_ $$aNiforou, K.$$b19
000144812 7001_ $$00000-0001-5201-172X$$aSieri, S.$$b20
000144812 7001_ $$aTumino, R.$$b21
000144812 7001_ $$00000-0002-8008-5096$$aSacerdote, C.$$b22
000144812 7001_ $$aBueno-de-Mesquita, B.$$b23
000144812 7001_ $$aSandanger, T. M.$$b24
000144812 7001_ $$aColorado-Yohar, S.$$b25
000144812 7001_ $$aSánchez, M. J.$$b26
000144812 7001_ $$aGil Majuelo, L.$$b27
000144812 7001_ $$aLujan-Barroso, L.$$b28
000144812 7001_ $$aArdanaz, E.$$b29
000144812 7001_ $$aMerino, S.$$b30
000144812 7001_ $$aIsaksson, K.$$b31
000144812 7001_ $$aButt, S.$$b32
000144812 7001_ $$aLjuslinder, I.$$b33
000144812 7001_ $$aJansson, M.$$b34
000144812 7001_ $$aTravis, R. C.$$b35
000144812 7001_ $$aKhaw, K. T.$$b36
000144812 7001_ $$00000-0003-2237-0128$$aWeiderpass, E.$$b37
000144812 7001_ $$aDossus, L.$$b38
000144812 7001_ $$00000-0002-6846-1204$$aRinaldi, S.$$b39
000144812 7001_ $$00000-0002-4557-3772$$aKvaskoff, M.$$b40
000144812 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.32674$$gp. ijc.32674$$n12$$p3267-3280$$tInternational journal of cancer$$v146$$x1097-0215$$y2020
000144812 909CO $$ooai:inrepo02.dkfz.de:144812$$pVDB
000144812 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000144812 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000144812 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000144812 9141_ $$y2020
000144812 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000144812 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144812 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144812 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144812 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2017
000144812 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144812 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000144812 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144812 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144812 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000144812 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000144812 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2017
000144812 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000144812 980__ $$ajournal
000144812 980__ $$aVDB
000144812 980__ $$aI:(DE-He78)C020-20160331
000144812 980__ $$aUNRESTRICTED